Clinical Trials Browser

Phase 1/2 × OTHER × Other solid neoplasm × Clear all

NCT06598371 2026-04-16

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Select Advanced Solid Tumors

NCT06306638 2026-04-06

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Phase 1/2 Recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT05036226 2026-03-30

COAST

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT03585465 2026-03-18

Metro-PD1

Phase 1/2 Active not recruiting

Other solid neoplasm

Childhood Solid Tumor

NCT07461181 2026-03-10

A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT00797719 2026-03-05

Short Neoadjuvant Hemithoracic IMRT for MPM

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT07446725 2026-03-03

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07394374 2026-02-06

A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion

NCT04627740 2026-01-20

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT06556108 2026-01-20

ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT05210413 2026-01-15

SPARTO

Phase 1/2 Active not recruiting

Other solid neoplasm

Refractory or Recurrent Solid Tumor

NCT07307053 2025-12-29

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Phase 1/2 Not yet recruiting

Other neoplasmOther solid neoplasm

Rare Malignant Neoplasm

NCT06840821 2025-12-02

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06439888 2025-12-01

LySATRA

Phase 1/2 Recruiting

Other solid neoplasm

Oligometastatic Disease

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT01375114 2025-10-28

The Effects of Ginseng on Cancer-Related Fatigue

Phase 1/2 Active not recruiting

165 enrolled 14 charts

Other solid neoplasm

Advanced Cancers

NCT02414269 2025-10-08

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Phase 1/2 Active not recruiting

BreastOther solid neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasm Metastasis

NCT05932199 2025-09-25

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Phase 1/2 Recruiting

Other solid neoplasmThoracic

Mesothelioma

NCT06027983 2025-09-23

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Phase 1/2 Not yet recruiting

BreastOther solid neoplasm

HER2+ Advanced Breast Cancer

NCT07170787 2025-09-12

A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT02992210 2025-09-08

Study on GD2 Positive Solid Tumors by 4SCAR-GD2

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Phase 1/2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT07121374 2025-08-13

NECIM

Phase 1/2 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01309490 2025-07-29

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Phase 1/2 Terminated

Other solid neoplasm

Malignant Solid Tumor

NCT05275777 2025-07-25

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

Phase 1/2 Active not recruiting

BreastOther solid neoplasm

HER2-negative Breast Cancer

NCT05978102 2025-07-23

A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05714553 2025-07-18

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Phase 1/2 Terminated

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Esophageal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06888830 2025-06-19

A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumours

NCT05944237 2025-06-08

HTL0039732 in Participants With Advanced Solid Tumours

Phase 1/2 Recruiting

EndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT06991478 2025-05-28

SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumor, Malignant Ascites

NCT06970132 2025-05-14

Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05038150 2025-04-30

Study of SGN1 in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05103345 2025-04-30

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT02649829 2025-04-29

MESODEC

Phase 1/2 Completed

GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

NCT06940349 2025-04-23

COPS-01

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors Refractory to Standard Therapy

NCT03523351 2025-04-20

Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

Phase 1/2 Completed

78 enrolled 10 charts

Other solid neoplasm

Metastatic Solid Tumors of Metastatic Disease

NCT06895733 2025-03-26

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05599048 2025-03-24

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05146440 2025-03-21

PRIME

Phase 1/2 Recruiting

Other solid neoplasmSarcoma

Advanced Soft-tissue Sarcoma

NCT06173219 2025-02-27

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT03707808 2025-01-20

myDAvIpNi

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT01291420 2024-12-09

Dendritic Cell Vaccination for Patients with Solid Tumors

Phase 1/2 Completed

BreastCNSGastrointestinalGenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Renal Cell, Glioblastoma, Sarcoma, Colorectal Neoplasms

NCT06310382 2024-07-08

GH55 for Advanced Cancers With MAPK Mutations: A Study on Safety and Early Results

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors With MAPK Signal Pathway Mutations

NCT06435455 2024-07-08

GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation

NCT06081907 2024-05-30

Promise

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT03319537 2024-05-23

Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

Phase 1/2 Terminated

9 enrolled 9 charts

Other solid neoplasmThoracic

Mesothelioma

NCT05765084 2024-05-16

Immuno-MESODEC

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

NCT05693844 2024-05-10

Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT03393858 2024-02-07

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Phase 1/2 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasms